EXTENSION STUDY OF AMIKACIN LIPOSOME INHALATION SUSPENSION (ALIS) FOR TREATMENT-REFRACTORY LUNG DISEASE CAUSED BY MYCOBACTERIUM AVIUM COMPLEX (MAC)

被引：2
|
作者：
Winthrop, Kevin [1 ]
Eagle, Gina [1 ]
Morimoto, Kozo [1 ]
Castellotti, Paola Francesca [1 ]
O'Donnell, Anne [1 ]
Ruoss, Stephen [1 ]
Aksamit, Timothy [1 ]
Nezamis, James [1 ]
Griffith, David [1 ]
机构：
[1] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
来源：
CHEST | 2018年 / 154卷 / 04期
关键词：
D O I：
10.1016/j.chest.2018.08.160
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：182A / 183A
页数：2
相关论文
共 50 条
  • [21] Amikacin Liposome Inhalation Suspension in the Real-World Management of Refractory Mycobacterium avium Complex Pulmonary Disease
    Yanagihara, Toyoshi
    Ogata, Hiroaki
    Mori, Asami
    Kadowaki, Masako
    Moriuchi, Yuki
    Ishimatsu, Akiko
    Otsuka, Junji
    Taguchi, Kazuhito
    Moriwaki, Atushi
    Yoshida, Makoto
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (03)
  • [22] Effectiveness of Amikacin liposome inhalation suspension for refractory Mycobacterium avium complex pulmonary disease at 6 months post initiation
    Urabe, Naohisa
    Sakamoto, Susumu
    Tokita, Nozomi
    Yoshida, Hiromichi
    Usui, Yusuke
    Shimizu, Hiroshige
    Sekiya, Muneyuki
    Miyoshi, Shion
    Nakamura, Yasuhiko
    Isobe, Kazutoshi
    Kishi, Kazuma
    [J]. BMC PULMONARY MEDICINE, 2024, 24 (01):
  • [23] Population Pharmacokinetic Evaluation of Amikacin Liposome Inhalation Suspension in Patients with Treatment-Refractory Nontuberculous Mycobacterial Lung Disease
    Christopher M. Rubino
    Nikolas J. Onufrak
    Jakko van Ingen
    David E. Griffith
    Sujata M. Bhavnani
    Dayton W. Yuen
    Kevin C. Mange
    Kevin L. Winthrop
    [J]. European Journal of Drug Metabolism and Pharmacokinetics, 2021, 46 : 277 - 287
  • [24] Population Pharmacokinetic Evaluation of Amikacin Liposome Inhalation Suspension in Patients with Treatment-Refractory Nontuberculous Mycobacterial Lung Disease
    Rubino, Christopher M.
    Onufrak, Nikolas J.
    van Ingen, Jakko
    Griffith, David E.
    Bhavnani, Sujata M.
    Yuen, Dayton W.
    Mange, Kevin C.
    Winthrop, Kevin L.
    [J]. EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2021, 46 (02) : 277 - 287
  • [25] Amikacin Liposome Inhalation Suspension for Mycobacterium avium Complex Lung Disease A 12-Month Open-Label Extension Clinical Trial
    Winthrop, Kevin L.
    Flume, Patrick A.
    Thomson, Rachel
    Mange, Kevin C.
    Yuen, Dayton W.
    Ciesielska, Monika
    Morimoto, Kozo
    Ruoss, Stephen J.
    Codecasa, Luigi R.
    Yim, Jae-Joon
    Marras, Theodore K.
    van Ingen, Jakko
    Wallace, Richard J., Jr.
    Brown-Elliott, Barbara A.
    Coulter, Chris
    Griffith, David E.
    [J]. ANNALS OF THE AMERICAN THORACIC SOCIETY, 2021, 18 (07) : 1147 - 1157
  • [26] Amikacin Liposome Inhalation Suspension in Refractory Mycobacterium avium Complex Lung Disease: A Profile of Its Use (vol 41, pg 405, 2021)
    Hoy, Sheridan M.
    [J]. CLINICAL DRUG INVESTIGATION, 2021, 41 (06) : 591 - 591
  • [27] A Retrospective Analysis to Assess the Discontinuation of Amikacin Liposome Inhalation Suspension Therapy Among Patients Treated for Refractory Mycobacterium Avium Complex Lung Disease
    Puc, M.
    Koerner, P.
    Russian, A.
    Faris, R.
    Vanscoy, G.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [28] Amikacin Liposome Inhalation Suspension: A Review in Mycobacterium avium Complex Lung Disease (vol 79, pg 555, 2019)
    Shirley, Matt
    [J]. DRUGS, 2019, 79 (07) : 791 - 791
  • [29] Amikacin Liposome Inhalation Suspension for Refractory Mycobacterium avium Complex Lung Disease Sustainability and Durability of Culture Conversion and Safety of Long-term Exposure
    Griffith, David E.
    Thomson, Rachel
    Flume, Patrick A.
    Aksamit, Timothy R.
    Field, Stephen K.
    Addrizzo-Harris, Doreen J.
    Morimoto, Kozo
    Hoefsloot, Wouter
    Mange, Kevin C.
    Yuen, Dayton W.
    Ciesielska, Monika
    Wallace, Richard J., Jr.
    van Ingen, Jakko
    Brown-Elliott, Barbara A.
    Coulter, Chris
    Winthrop, Kevin L.
    [J]. CHEST, 2021, 160 (03) : 831 - 842
  • [30] THE RELATIONSHIP BETWEEN CULTURE CONVERSION AND IMPROVEMENT IN 6-MINUTE WALK TEST DISTANCE IN THE CONVERT STUDY EVALUATING AMIKACIN LIPOSOME INHALATION SUSPENSION FOR REFRACTORY MYCOBACTERIUM AVIUM COMPLEX (MAC) LUNG DISEASE
    Mange, Kevin
    Roberts, Kevin
    Zandvliet, Anthe
    Witjes, Han
    Neve, Marta
    Lovern, Mark
    [J]. CHEST, 2019, 156 (04) : 1126A - 1126A
12345